J. Safra Asset Management’s Core Laboratories CLB Stock Holding History

J. Safra Asset Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-309	Closed	-$35K	–	47
2016 Q3	$35K	Hold	309	–	–	0.06%	73
2016 Q2	$38K	Buy	+309	New	+$37.3K	0.06%	115

Other funds holding CLB

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

WCM Investment Management Laguna Beach, California $43.8B AUM 42.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Wedgewood Partners St Louis, Missouri $484M AUM 14.59% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

SGA

Sustainable Growth Advisers Stamford, Connecticut $10.6B AUM 2.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

J. Safra Asset Management's CLB Position: Q4 2016 in Review

J. Safra Asset Management sold out of Core Laboratories (CLB) in Q4 2016, closing a stake of 309 shares — an estimated $35K sold.

J. Safra Asset Management first reported a position in CLB in Q2 2016 and held it in 2 quarters. The position peaked at $38K in Q2 2016. 372 funds tracked by Wall St. Rank hold CLB as of Q4 2016.

J. Safra Asset Management reported no remaining Core Laboratories position as of Q4 2016 after selling out during the quarter.
J. Safra Asset Management sold 309 Core Laboratories shares in Q4 2016, an estimated $35K.
J. Safra Asset Management first reported a position in Core Laboratories in Q2 2016 and held it in 2 quarters.
J. Safra Asset Management's Core Laboratories position peaked at $38K in Q2 2016.
372 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2016.

Based on J. Safra Asset Management's 13F filing for Q4 2016, filed 9 Feb 2017.